NCT04275024View on ClinicalTrials.gov

Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

June 17, 2020

Study Completion Date

February 3, 2021

Conditions
Mesenchymal Stromal CellsPsoriasisDrug EffectDrug Toxicity
Interventions
DRUG

Calcipotriol ointment

The topical treatment in the study was calcipotriol ointment(Dovonex;LEO Laboratories Ltd, Ireland) twice daily for 12 weeks.

DRUG

PSORI-CM01 Granule

PSORI-CM01#YXBCM01# granule 5.5g os once a day for 12weeks.

BIOLOGICAL

adipose-derived multipotent mesenchymal stem cells

AD-MSCs(adipose-derived multipotent mesenchymal stem cells) were infused intravenously at a dose of 2 million cells/kg

Trial Locations (1)

Unknown

Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou

All Listed Sponsors
lead

Guangdong Provincial Hospital of Traditional Chinese Medicine

OTHER

NCT04275024 - Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients | Biotech Hunter | Biotech Hunter